APOB and Hypercholesterolemia: To investigate the observed hypercholesterolemia, we assessed apoB secretion by 35S steady-state protein labelling in TMEM199-deficient patient-derived hepatocyte-like cells (HLCs) and found significantly increased apoB secretion (42% increase; P = .008; Figure 2A) as compared with controls.